Segall Bryant & Hamill LLC Increases Holdings in iRhythm Technologies, Inc. (NASDAQ:IRTC)

Segall Bryant & Hamill LLC grew its position in shares of iRhythm Technologies, Inc. (NASDAQ:IRTC) by 5.1% during the 4th quarter, Holdings Channel.com reports. The institutional investor owned 139,391 shares of the company’s stock after acquiring an additional 6,789 shares during the quarter. Segall Bryant & Hamill LLC’s holdings in iRhythm Technologies were worth $12,569,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds have also recently modified their holdings of the company. Eventide Asset Management LLC lifted its position in iRhythm Technologies by 170.8% during the third quarter. Eventide Asset Management LLC now owns 736,721 shares of the company’s stock valued at $54,694,000 after purchasing an additional 464,629 shares in the last quarter. Braidwell LP lifted its position in shares of iRhythm Technologies by 48.7% during the 3rd quarter. Braidwell LP now owns 782,557 shares of the company’s stock valued at $58,097,000 after buying an additional 256,200 shares in the last quarter. Stephens Investment Management Group LLC grew its stake in shares of iRhythm Technologies by 25.6% during the 4th quarter. Stephens Investment Management Group LLC now owns 502,925 shares of the company’s stock valued at $45,349,000 after acquiring an additional 102,600 shares during the period. Raymond James Financial Inc. bought a new position in shares of iRhythm Technologies in the fourth quarter worth approximately $9,151,000. Finally, Bank of New York Mellon Corp increased its stake in iRhythm Technologies by 23.2% in the 4th quarter. Bank of New York Mellon Corp now owns 491,485 shares of the company’s stock worth $44,317,000 after buying an additional 92,591 shares in the last quarter.

iRhythm Technologies Stock Up 0.7 %

Shares of NASDAQ IRTC opened at $106.60 on Wednesday. The company has a current ratio of 6.27, a quick ratio of 6.12 and a debt-to-equity ratio of 9.00. iRhythm Technologies, Inc. has a 12-month low of $55.92 and a 12-month high of $128.52. The firm’s 50-day moving average price is $108.14 and its 200-day moving average price is $89.47. The stock has a market capitalization of $3.35 billion, a price-to-earnings ratio of -29.29 and a beta of 1.36.

iRhythm Technologies (NASDAQ:IRTC) last issued its quarterly earnings data on Thursday, February 20th. The company reported $0.01 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.29) by $0.30. The business had revenue of $164.33 million for the quarter, compared to the consensus estimate of $158.30 million. iRhythm Technologies had a negative return on equity of 118.83% and a negative net margin of 19.14%. On average, equities research analysts anticipate that iRhythm Technologies, Inc. will post -1.98 EPS for the current fiscal year.

Analyst Ratings Changes

A number of research analysts recently commented on the company. Canaccord Genuity Group boosted their price target on iRhythm Technologies from $125.00 to $152.00 and gave the stock a “buy” rating in a report on Monday, December 9th. Oppenheimer boosted their target price on shares of iRhythm Technologies from $105.00 to $120.00 and gave the stock an “outperform” rating in a report on Wednesday, January 8th. Needham & Company LLC raised their target price on shares of iRhythm Technologies from $125.00 to $138.00 and gave the company a “buy” rating in a research note on Friday, February 21st. The Goldman Sachs Group boosted their price target on shares of iRhythm Technologies from $91.00 to $124.00 and gave the stock a “neutral” rating in a research note on Monday, February 24th. Finally, StockNews.com upgraded iRhythm Technologies from a “sell” rating to a “hold” rating in a research report on Monday, February 24th. Three analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. According to data from MarketBeat, iRhythm Technologies presently has an average rating of “Moderate Buy” and a consensus price target of $119.73.

About iRhythm Technologies

iRhythm Technologies, Inc, a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services.